Griffin JH - Search Results

1

A single genetic origin for a common Caucasian risk factor for venous thrombosis.

Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U. Zivelin A, et al. Among authors: griffin jh. Blood. 1997 Jan 15;89(2):397-402. Blood. 1997. PMID: 9002940 Free article.

2

Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.

Heeb MJ, Kojima Y, Greengard JS, Griffin JH. Heeb MJ, et al. Among authors: griffin jh. Blood. 1995 Jun 15;85(12):3405-11. Blood. 1995. PMID: 7780127 Free article.

3

Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia.

Sun X, Evatt B, Griffin JH. Sun X, et al. Among authors: griffin jh. Blood. 1994 Jun 1;83(11):3120-5. Blood. 1994. PMID: 8193349 Free article.

4

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency.

Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou MH, Samama MM, Rosenberg RD. Conard J, et al. Among authors: griffin jh. Blood. 1993 Aug 15;82(4):1159-64. Blood. 1993. PMID: 8353282 Free article.

5

Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.

Greengard JS, Xu X, Gandrille S, Griffin JH. Greengard JS, et al. Among authors: griffin jh. Thromb Res. 1995 Dec 1;80(5):441-3. doi: 10.1016/0049-3848(95)00197-y. Thromb Res. 1995. PMID: 8588206 No abstract available.

6

Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.

Brenner B, Zivelin A, Lanir N, Greengard JS, Griffin JH, Seligsohn U. Brenner B, et al. Among authors: griffin jh. Blood. 1996 Aug 1;88(3):877-80. Blood. 1996. PMID: 8704244 Free article.

7

Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms.

Xu X, Bauer KA, Griffin JH. Xu X, et al. Among authors: griffin jh. Thromb Res. 1999 Mar 15;93(6):265-9. doi: 10.1016/s0049-3848(98)00178-9. Thromb Res. 1999. PMID: 10093967

8

Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C.

Zivelin A, Gitel S, Griffin JH, Xu X, Fernandez JA, Martinowitz U, Cohen Y, Halkin H, Seligsohn U, Inbal A. Zivelin A, et al. Among authors: griffin jh. Blood. 1999 Aug 1;94(3):895-901. Blood. 1999. PMID: 10419879 Free article.

9

Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.

Deguchi H, Fernández JA, Pabinger I, Heit JA, Griffin JH. Deguchi H, et al. Among authors: griffin jh. Blood. 2001 Apr 1;97(7):1907-14. doi: 10.1182/blood.v97.7.1907. Blood. 2001. PMID: 11264150 Free article.

10

Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model.

Fernández JA, Xu X, Liu D, Zlokovic BV, Griffin JH. Fernández JA, et al. Among authors: griffin jh. Blood Cells Mol Dis. 2003 May-Jun;30(3):271-6. doi: 10.1016/s1079-9796(03)00034-2. Blood Cells Mol Dis. 2003. PMID: 12737945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters